# Improving Preterm Kidney Outcomes With Caffeine

> **NCT07262060** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 114 (estimated)

## Conditions studied

- Kidney Injury
- Pre-Term

## Interventions

- **DRUG:** Caffeine citrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07262060
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2030-03
- **Final completion:** 2030-09
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2026-04-03

## Collaborators

- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07262060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07262060, "Improving Preterm Kidney Outcomes With Caffeine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07262060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*